Patent · US Active

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases

US10155004B2 · kind B2 · utility

2Cited by

23References

3Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Wolfgang Schwede · Berlin, DE
Ulrich Klar · Berlin, DE
Carsten Möller · Berlin, DE
Andrea Rotgeri · Berlin, DE
Wilhelm Bone · Berlin, DE

Key dates

Filing date	Apr 4, 2017
Grant date	Dec 18, 2018
Priority date	—
Expiry date	Apr 4, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07J41/0083
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives of Formula I with progesterone antagonizing action and method of production thereof, use thereof for the treatment and/or prophylaxis of diseases and use thereof for the production of medicinal products for the treatment and/or prophylaxis of diseases, in particular of fibroids of the uterus (myomas, uterine leiomyoma), endometriosis, heavy menstrual bleeds, meningiomas, hormone-dependent breast cancers and complaints associated with the menopause or for fertility control and emergency contraception.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.